Gene Panel Market by Product & Service, Technique (Amplicon, Hybridization), Design (Predesign, Custom), Application (Cancer, Congenital Disease, Pharmacogenetics) & End User (Hospital, Research Center, Pharmaceutical Companies) - Global Forecast to 2023
“The global gene panels market projected to grow at a CAGR of 19.2%.”
The global gene panels market is expected to reach USD 2.95 billion by 2023 from USD 1.22 billion in 2018, at a CAGR of 19.2%. This market is experiencing significant growth due increasing prevalence of chronic diseases, growing company initiatives (in terms of strategic partnerships, collaborations, and product launches), and growing adoption of gene panels owing to the benefits they offer. However, issues related to the security of genetic data and accuracy & standardization concerns in diagnostic testing are restricting the growth of this market
“The testing services segment is projected to grow at the highest CAGR during the forecast period.”
Based on product & service, the market is segmented into test kits and testing services. The test services segment is projected to register the highest CAGR during the forecast period. Factors such as the increasing focus of market players on providing efficient gene panel services to researchers and the growing number of government funding programs for genomic research are likely to drive the market for gene panel testing services.
“By application, the cancer risk assessment segment held the largest share of the market during the forecast period.”
Based on applications, the market is segmented into cancer risk assessment, diagnosis of congenital diseases, pharmacogenetics, and other applications. The cancer risk assessment segment held the largest share of the gene panels market in 2018. It is also projected to register the highest growth during the forecast period due to the increasing incidence of cancer and the growing demand for gene panels in research and diagnostics to understand the genetic variability of cancer.
“North America to witness the highest growth during the forecast period.”
In 2018, North America is expected to account for the largest share of the market followed by Europe. North America is also projected to register the highest CAGR during the forecast period. This can be attributed to factors such as the government support for genomics research, presence of leading NGS providers, and growing research on cancer and inherited rare diseases in the region.
The primary interviews conducted for this report can be categorized as follows:
The report provides an overview of the gene panels market. It aims at estimating the market size and future growth potential of this market across different segments such as product & service, technique, design, application, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall gene panels market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report will also help stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.
The global gene panels market is expected to reach USD 2.95 billion by 2023 from USD 1.22 billion in 2018, at a CAGR of 19.2%. This market is experiencing significant growth due increasing prevalence of chronic diseases, growing company initiatives (in terms of strategic partnerships, collaborations, and product launches), and growing adoption of gene panels owing to the benefits they offer. However, issues related to the security of genetic data and accuracy & standardization concerns in diagnostic testing are restricting the growth of this market
“The testing services segment is projected to grow at the highest CAGR during the forecast period.”
Based on product & service, the market is segmented into test kits and testing services. The test services segment is projected to register the highest CAGR during the forecast period. Factors such as the increasing focus of market players on providing efficient gene panel services to researchers and the growing number of government funding programs for genomic research are likely to drive the market for gene panel testing services.
“By application, the cancer risk assessment segment held the largest share of the market during the forecast period.”
Based on applications, the market is segmented into cancer risk assessment, diagnosis of congenital diseases, pharmacogenetics, and other applications. The cancer risk assessment segment held the largest share of the gene panels market in 2018. It is also projected to register the highest growth during the forecast period due to the increasing incidence of cancer and the growing demand for gene panels in research and diagnostics to understand the genetic variability of cancer.
“North America to witness the highest growth during the forecast period.”
In 2018, North America is expected to account for the largest share of the market followed by Europe. North America is also projected to register the highest CAGR during the forecast period. This can be attributed to factors such as the government support for genomics research, presence of leading NGS providers, and growing research on cancer and inherited rare diseases in the region.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 – 30%; Tier 2 - 42%; Tier 3 - 28%
- By Designation: C-level- 25%; D-level- 45%; Others- 30%
- By Region: North America-48%; Europe-29%; Asia Pacific-19%; Rest of the World-4%
- Illumina, Inc. (US)
- Thermo Fisher Scientific (US)
- Agilent Technologies (US)
- QIAGEN (Germany)
- BGI (China)
- Eurofins Scientific (US)
- F. Hoffmann-La Roche AG (Switzerland)
- Integrated DNA Technologies (US)
- GATC Biotech AG (Germany)
- GENEWIZ, Inc. (US)
- Novogene Corporation (China)
- Personalis (US)
- ArcherDx (US).
The report provides an overview of the gene panels market. It aims at estimating the market size and future growth potential of this market across different segments such as product & service, technique, design, application, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall gene panels market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report will also help stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKET COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 SECONDARY DATA
2.2 PRIMARY DATA
2.3 KEY INDUSTRY INSIGHTS
2.4 MARKET SIZE ESTIMATION
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 GENE PANELS MARKET OVERVIEW
4.2 GENE PANELS MARKET, BY TYPE, 2018–2023
4.3 GENE PANELS MARKET, BY END USER, 2018 VS. 2023 (USD BILLION)
4.4 GEOGRAPHIC ANALYSIS: GENE PANELS MARKET IN EUROPE, BY APPLICATION
4.5 GEOGRAPHICAL SNAPSHOT OF THE GENE PANELS MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing prevalence of chronic diseases
5.2.1.2 Growing company initiatives
5.2.1.3 Benefits of gene panels
5.2.2 RESTRAINTS
5.2.2.1 Issues related to the security of genetic data
5.2.3 OPPORTUNITIES
5.2.3.1 Government initiatives in population sequencing
5.2.3.2 Growth opportunities in emerging markets
5.2.4 CHALLENGES
5.2.4.1 Accuracy and standardization concerns in diagnostic testing
6 GENE PANELS MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
6.2 TEST KITS
6.3 TESTING SERVICES
7 GENE PANELS MARKET, BY TECHNIQUE
7.1 INTRODUCTION
7.2 AMPLICON-BASED APPROACH
7.3 HYBRIDIZATION-BASED APPROACH
8 GENE PANELS MARKET, BY DESIGN
8.1 INTRODUCTION
8.2 PREDESIGNED GENE PANELS
8.3 CUSTOMIZED GENE PANELS
9 GENE PANELS MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 CANCER RISK ASSESSMENT
9.2.1 SYNDROME-SPECIFIC GENE PANELS
9.2.2 HIGH-PENETRANCE GENE PANELS
9.2.3 HIGH AND MODERATE-PENETRANCE GENE PANELS
9.2.4 COMPREHENSIVE CANCER RISK PANELS
9.3 PHARMACOGENETICS
9.4 DIAGNOSIS OF CONGENITAL DISORDERS
9.5 OTHER APPLICATIONS
10 GENE PANELS MARKET, BY END USER
10.1 INTRODUCTION
10.2 RESEARCH & ACADEMIC INSTITUTES
10.3 HOSPITALS & DIAGNOSTIC LABORATORIES
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
11 GENE PANELS MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.2 CANADA
11.3 EUROPE
11.3.1 GERMANY
11.3.2 UK
11.3.3 FRANCE
11.3.4 REST OF EUROPE (ROE)
11.4 ASIA PACIFIC
11.5 REST OF THE WORLD (ROW)
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 MARKET SHARE ANALYSIS
12.3 COMPETITIVE SITUATION AND TRENDS
12.3.1 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
12.3.2 PRODUCT LAUNCHES AND UPGRADES
12.3.3 ACQUISITIONS
12.3.4 EXPANSIONS
13 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 ILLUMINA, INC.
13.2 THERMO FISHER SCIENTIFIC INC.
13.3 AGILENT
13.4 QIAGEN
13.5 EUROFINS SCIENTIFIC SE
13.6 BGI
13.7 F. HOFFMANN-LA ROCHE AG
13.8 INTEGRATED DNA TECHNOLOGIES
13.9 GENEWIZ, INC.
13.10 NOVOGENE CORPORATION
13.11 PERSONALIS, INC.
13.12 GATC BIOTECH AG
13.13 ARCHERDX
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
14 APPENDIX
14.1 INSIGHTS OF INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
14.5 AVAILABLE CUSTOMIZATIONS
14.6 RELATED REPORTS
14.7 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKET COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 SECONDARY DATA
2.2 PRIMARY DATA
2.3 KEY INDUSTRY INSIGHTS
2.4 MARKET SIZE ESTIMATION
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 GENE PANELS MARKET OVERVIEW
4.2 GENE PANELS MARKET, BY TYPE, 2018–2023
4.3 GENE PANELS MARKET, BY END USER, 2018 VS. 2023 (USD BILLION)
4.4 GEOGRAPHIC ANALYSIS: GENE PANELS MARKET IN EUROPE, BY APPLICATION
4.5 GEOGRAPHICAL SNAPSHOT OF THE GENE PANELS MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing prevalence of chronic diseases
5.2.1.2 Growing company initiatives
5.2.1.3 Benefits of gene panels
5.2.2 RESTRAINTS
5.2.2.1 Issues related to the security of genetic data
5.2.3 OPPORTUNITIES
5.2.3.1 Government initiatives in population sequencing
5.2.3.2 Growth opportunities in emerging markets
5.2.4 CHALLENGES
5.2.4.1 Accuracy and standardization concerns in diagnostic testing
6 GENE PANELS MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
6.2 TEST KITS
6.3 TESTING SERVICES
7 GENE PANELS MARKET, BY TECHNIQUE
7.1 INTRODUCTION
7.2 AMPLICON-BASED APPROACH
7.3 HYBRIDIZATION-BASED APPROACH
8 GENE PANELS MARKET, BY DESIGN
8.1 INTRODUCTION
8.2 PREDESIGNED GENE PANELS
8.3 CUSTOMIZED GENE PANELS
9 GENE PANELS MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 CANCER RISK ASSESSMENT
9.2.1 SYNDROME-SPECIFIC GENE PANELS
9.2.2 HIGH-PENETRANCE GENE PANELS
9.2.3 HIGH AND MODERATE-PENETRANCE GENE PANELS
9.2.4 COMPREHENSIVE CANCER RISK PANELS
9.3 PHARMACOGENETICS
9.4 DIAGNOSIS OF CONGENITAL DISORDERS
9.5 OTHER APPLICATIONS
10 GENE PANELS MARKET, BY END USER
10.1 INTRODUCTION
10.2 RESEARCH & ACADEMIC INSTITUTES
10.3 HOSPITALS & DIAGNOSTIC LABORATORIES
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
11 GENE PANELS MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.2 CANADA
11.3 EUROPE
11.3.1 GERMANY
11.3.2 UK
11.3.3 FRANCE
11.3.4 REST OF EUROPE (ROE)
11.4 ASIA PACIFIC
11.5 REST OF THE WORLD (ROW)
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 MARKET SHARE ANALYSIS
12.3 COMPETITIVE SITUATION AND TRENDS
12.3.1 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
12.3.2 PRODUCT LAUNCHES AND UPGRADES
12.3.3 ACQUISITIONS
12.3.4 EXPANSIONS
13 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 ILLUMINA, INC.
13.2 THERMO FISHER SCIENTIFIC INC.
13.3 AGILENT
13.4 QIAGEN
13.5 EUROFINS SCIENTIFIC SE
13.6 BGI
13.7 F. HOFFMANN-LA ROCHE AG
13.8 INTEGRATED DNA TECHNOLOGIES
13.9 GENEWIZ, INC.
13.10 NOVOGENE CORPORATION
13.11 PERSONALIS, INC.
13.12 GATC BIOTECH AG
13.13 ARCHERDX
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
14 APPENDIX
14.1 INSIGHTS OF INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
14.5 AVAILABLE CUSTOMIZATIONS
14.6 RELATED REPORTS
14.7 AUTHOR DETAILS
LIST OF TABLES
Table 1 GENE PANELS MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
Table 2 TEST KITS MARKET, BY REGION, 2018-2023 (USD MILLION)
Table 3 TESTING SERVICES MARKET, BY REGION, 2018-2023 (USD MILLION)
Table 4 GENE PANELS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
Table 5 GENE PANELS MARKET FOR AMPLICON-BASED APPROACH, BY REGION, 2016–2023 (USD MILLION)
Table 6 GENE PANELS MARKET FOR HYBRIDIZATION-BASED APPROACH, BY REGION, 2016–2023 (USD MILLION)
Table 7 GENE PANELS MARKET, BY DESIGN, 2018-2022 (USD MILLION)
Table 8 PREDESIGNED GENE PANELS MARKET, BY REGION, 2018-2023 (USD MILLION)
Table 9 CUSTOMIZED GENE PANELS MARKET, BY REGION, 2018-2023 (USD MILLION)
Table 10 GENE PANELS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
Table 11 GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY REGION, 2018-2022 (USD MILLION)
Table 12 GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY TYPE, 2018-2022 (USD MILLION)
Table 13 SYNDROME-SPECIFIC GENE PANELS MARKET, BY REGION, 2018-2022 (USD MILLION)
Table 14 HIGH-PENETRANCE GENE PANELS MARKET, BY REGION, 2018-2022 (USD MILLION)
Table 15 HIGH AND MODERATE-PENETRANCE GENE PANELS MARKET, BY REGION, 2018-2022 (USD MILLION)
Table 16 COMPREHENSIVE CANCER RISK GENE PANELS MARKET, BY REGION, 2018-2022 (USD MILLION)
Table 17 GENE PANELS MARKET FOR PHARMACOGENETICS, BY REGION, 2018-2022 (USD MILLION)
Table 18 GENE PANELS MARKET FOR THE DIAGNOSIS OF CONGENITAL DISORDERS, BY REGION, 2018-2022 (USD MILLION)
Table 19 GENE PANELS MARKET FOR OTHER APPLICATIONS, BY REGION, 2018-2022 (USD MILLION)
Table 20 GENE PANELS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 21 GENE PANELS MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2016–2023 (USD MILLION)
Table 22 GENE PANELS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2016–2023 (USD MILLION)
Table 23 GENE PANELS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2023 (USD MILLION)
Table 24 GENE PANELS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 25 NORTH AMERICA: GENE PANELS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 26 NORTH AMERICA: GENE PANELS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 27 NORTH AMERICA: GENE PANELS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
Table 28 NORTH AMERICA: GENE PANELS MARKET, BY DESIGN, 2016–2023 (USD MILLION)
Table 29 NORTH AMERICA: GENE PANELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 30 NORTH AMERICA: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY TYPE, 2016–2023 (USD MILLION)
Table 31 NORTH AMERICA: GENE PANELS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 32 US: GENE PANELS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 33 US: GENE PANELS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
Table 34 US: GENE PANELS MARKET, BY DESIGN, 2016–2023 (USD MILLION)
Table 35 US: GENE PANELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 36 US: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY TYPE, 2016–2023 (USD MILLION)
Table 37 US: GENE PANELS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 38 CANADA: GENE PANELS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 39 CANADA: GENE PANELS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
Table 40 CANADA: GENE PANELS MARKET, BY DESIGN, 2016–2023 (USD MILLION)
Table 41 CANADA: GENE PANELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 42 CANADA: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY TYPE, 2016–2023 (USD MILLION)
Table 43 CANADA: GENE PANELS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 44 EUROPE: GENE PANELS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 45 EUROPE: GENE PANELS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 46 EUROPE: GENE PANELS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
Table 47 EUROPE: GENE PANELS MARKET, BY DESIGN, 2016–2023 (USD MILLION)
Table 48 EUROPE: GENE PANELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 49 EUROPE: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY TYPE, 2016–2023 (USD MILLION)
Table 50 EUROPE: GENE PANELS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 51 GERMANY: GENE PANELS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 52 GERMANY: GENE PANELS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
Table 53 GERMANY: GENE PANELS MARKET, BY DESIGN, 2016–2023 (USD MILLION)
Table 54 GERMANY: GENE PANELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 55 GERMANY: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY TYPE, 2016–2023 (USD MILLION)
Table 56 GERMANY: GENE PANELS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 57 UK: GENE PANELS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 58 UK: GENE PANELS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
Table 59 UK: GENE PANELS MARKET, BY DESIGN, 2016–2023 (USD MILLION)
Table 60 UK: GENE PANELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 61 UK: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY TYPE, 2016–2023 (USD MILLION)
Table 62 UK: GENE PANELS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 63 FRANCE: GENE PANELS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 64 FRANCE: GENE PANELS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
Table 65 FRANCE: GENE PANELS MARKET, BY DESIGN, 2016–2023 (USD MILLION)
Table 66 FRANCE: GENE PANELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 67 FRANCE: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY TYPE, 2016–2023 (USD MILLION)
Table 68 FRANCE: GENE PANELS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 69 ROE: GENE PANELS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 70 ROE: GENE PANELS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
Table 71 ROE: GENE PANELS MARKET, BY DESIGN, 2016–2023 (USD MILLION)
Table 72 ROE: GENE PANELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 73 ROE: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY TYPE, 2016–2023 (USD MILLION)
Table 74 ROE: GENE PANELS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 75 APAC: GENE PANELS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 76 APAC: GENE PANELS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
Table 77 APAC: GENE PANELS MARKET, BY DESIGN, 2016–2023 (USD MILLION)
Table 78 APAC: GENE PANELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 79 APAC: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY TYPE, 2016–2023 (USD MILLION)
Table 80 APAC: GENE PANELS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 81 ROW: GENE PANELS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 82 ROW: GENE PANELS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
Table 83 ROW: GENE PANELS MARKET, BY DESIGN, 2016–2023 (USD MILLION)
Table 84 ROW: GENE PANELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 85 ROW: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY TYPE, 2016–2023 (USD MILLION)
Table 86 ROW: GENE PANELS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 1 GENE PANELS MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
Table 2 TEST KITS MARKET, BY REGION, 2018-2023 (USD MILLION)
Table 3 TESTING SERVICES MARKET, BY REGION, 2018-2023 (USD MILLION)
Table 4 GENE PANELS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
Table 5 GENE PANELS MARKET FOR AMPLICON-BASED APPROACH, BY REGION, 2016–2023 (USD MILLION)
Table 6 GENE PANELS MARKET FOR HYBRIDIZATION-BASED APPROACH, BY REGION, 2016–2023 (USD MILLION)
Table 7 GENE PANELS MARKET, BY DESIGN, 2018-2022 (USD MILLION)
Table 8 PREDESIGNED GENE PANELS MARKET, BY REGION, 2018-2023 (USD MILLION)
Table 9 CUSTOMIZED GENE PANELS MARKET, BY REGION, 2018-2023 (USD MILLION)
Table 10 GENE PANELS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
Table 11 GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY REGION, 2018-2022 (USD MILLION)
Table 12 GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY TYPE, 2018-2022 (USD MILLION)
Table 13 SYNDROME-SPECIFIC GENE PANELS MARKET, BY REGION, 2018-2022 (USD MILLION)
Table 14 HIGH-PENETRANCE GENE PANELS MARKET, BY REGION, 2018-2022 (USD MILLION)
Table 15 HIGH AND MODERATE-PENETRANCE GENE PANELS MARKET, BY REGION, 2018-2022 (USD MILLION)
Table 16 COMPREHENSIVE CANCER RISK GENE PANELS MARKET, BY REGION, 2018-2022 (USD MILLION)
Table 17 GENE PANELS MARKET FOR PHARMACOGENETICS, BY REGION, 2018-2022 (USD MILLION)
Table 18 GENE PANELS MARKET FOR THE DIAGNOSIS OF CONGENITAL DISORDERS, BY REGION, 2018-2022 (USD MILLION)
Table 19 GENE PANELS MARKET FOR OTHER APPLICATIONS, BY REGION, 2018-2022 (USD MILLION)
Table 20 GENE PANELS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 21 GENE PANELS MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2016–2023 (USD MILLION)
Table 22 GENE PANELS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2016–2023 (USD MILLION)
Table 23 GENE PANELS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2023 (USD MILLION)
Table 24 GENE PANELS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 25 NORTH AMERICA: GENE PANELS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 26 NORTH AMERICA: GENE PANELS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 27 NORTH AMERICA: GENE PANELS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
Table 28 NORTH AMERICA: GENE PANELS MARKET, BY DESIGN, 2016–2023 (USD MILLION)
Table 29 NORTH AMERICA: GENE PANELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 30 NORTH AMERICA: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY TYPE, 2016–2023 (USD MILLION)
Table 31 NORTH AMERICA: GENE PANELS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 32 US: GENE PANELS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 33 US: GENE PANELS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
Table 34 US: GENE PANELS MARKET, BY DESIGN, 2016–2023 (USD MILLION)
Table 35 US: GENE PANELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 36 US: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY TYPE, 2016–2023 (USD MILLION)
Table 37 US: GENE PANELS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 38 CANADA: GENE PANELS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 39 CANADA: GENE PANELS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
Table 40 CANADA: GENE PANELS MARKET, BY DESIGN, 2016–2023 (USD MILLION)
Table 41 CANADA: GENE PANELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 42 CANADA: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY TYPE, 2016–2023 (USD MILLION)
Table 43 CANADA: GENE PANELS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 44 EUROPE: GENE PANELS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 45 EUROPE: GENE PANELS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 46 EUROPE: GENE PANELS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
Table 47 EUROPE: GENE PANELS MARKET, BY DESIGN, 2016–2023 (USD MILLION)
Table 48 EUROPE: GENE PANELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 49 EUROPE: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY TYPE, 2016–2023 (USD MILLION)
Table 50 EUROPE: GENE PANELS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 51 GERMANY: GENE PANELS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 52 GERMANY: GENE PANELS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
Table 53 GERMANY: GENE PANELS MARKET, BY DESIGN, 2016–2023 (USD MILLION)
Table 54 GERMANY: GENE PANELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 55 GERMANY: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY TYPE, 2016–2023 (USD MILLION)
Table 56 GERMANY: GENE PANELS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 57 UK: GENE PANELS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 58 UK: GENE PANELS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
Table 59 UK: GENE PANELS MARKET, BY DESIGN, 2016–2023 (USD MILLION)
Table 60 UK: GENE PANELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 61 UK: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY TYPE, 2016–2023 (USD MILLION)
Table 62 UK: GENE PANELS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 63 FRANCE: GENE PANELS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 64 FRANCE: GENE PANELS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
Table 65 FRANCE: GENE PANELS MARKET, BY DESIGN, 2016–2023 (USD MILLION)
Table 66 FRANCE: GENE PANELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 67 FRANCE: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY TYPE, 2016–2023 (USD MILLION)
Table 68 FRANCE: GENE PANELS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 69 ROE: GENE PANELS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 70 ROE: GENE PANELS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
Table 71 ROE: GENE PANELS MARKET, BY DESIGN, 2016–2023 (USD MILLION)
Table 72 ROE: GENE PANELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 73 ROE: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY TYPE, 2016–2023 (USD MILLION)
Table 74 ROE: GENE PANELS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 75 APAC: GENE PANELS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 76 APAC: GENE PANELS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
Table 77 APAC: GENE PANELS MARKET, BY DESIGN, 2016–2023 (USD MILLION)
Table 78 APAC: GENE PANELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 79 APAC: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY TYPE, 2016–2023 (USD MILLION)
Table 80 APAC: GENE PANELS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 81 ROW: GENE PANELS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 82 ROW: GENE PANELS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
Table 83 ROW: GENE PANELS MARKET, BY DESIGN, 2016–2023 (USD MILLION)
Table 84 ROW: GENE PANELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 85 ROW: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY TYPE, 2016–2023 (USD MILLION)
Table 86 ROW: GENE PANELS MARKET, BY END USER, 2016–2023 (USD MILLION)
LIST OF FIGURES
Figure 1 GENE PANELS MARKET SEGMENTATION
Figure 2 RESEARCH DESIGN
Figure 3 KEY DATA FROM SECONDARY SOURCES
Figure 4 KEY DATA FROM PRIMARY SOURCES
Figure 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
Figure 6 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
Figure 7 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 8 DATA TRIANGULATION METHODOLOGY
Figure 9 GENE PANELS MARKET, BY TYPE, 2018 VS. 2023 (USD BILLION)
Figure 10 GENE PANELS MARKET, BY TECHNIQUE, 2018 VS. 2023 (USD BILLION)
Figure 11 GENE PANELS MARKET, BY DESIGN, 2018 VS. 2023 (USD BILLION)
Figure 12 GENE PANELS MARKET, BY APPLICATION, 2018 VS. 2023 (USD BILLION)
Figure 13 GENE PANELS MARKET, BY END USER, 2018 VS. 2023 (USD BILLION)
Figure 14 GLOBAL GENE PANELS MARKET, BY REGION, 2018–2023
Figure 15 INCREASING PREVALENCE OF CHRONIC DISEASES ONE OF THE MAJOR FACTORS DRIVING THE GROWTH OF THE GLOBAL GENE PANELS MARKET
Figure 16 TESTING SERVICES SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 17 RESEARCH AND ACADEMIC INSTITUTES TO CONTINUE TO DOMINATE THE GENE PANELS MARKET IN 2023
Figure 18 CANCER RISK ASSESSMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE GENE PANELS MARKET IN EUROPE IN 2018
Figure 19 US TO DOMINATE THE GENE PANELS MARKET IN 2018
Figure 20 GENE PANELS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
Figure 21 TEST KITS ACCOUNTED FOR LARGEST SHARE OF THE GENE PANELS MARKET IN 2018
Figure 22 AMPLICON-BASED APPROACH TO RESISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
Figure 23 PREDESIGNED GENE PANELS TO ACCOUNT FOR THE LARGEST SHARE OF THE GENE PANELS MARKET IN 2018
Figure 24 CANCER RISK ASSESSMENT ACCOUNTED FOR LARGEST SHARE OF THE GENE PANELS MARKET IN 2018
Figure 25 RESEARCH & ACADEMIC INSTITUTES TO ACCOUNT FOR LARGEST SHARE OF THE GENE PANELS MARKET IN 2018
Figure 26 NORTH AMERICA: GENE PANELS MARKET SNAPSHOT, 2018
Figure 27 EUROPE: GENE PANELS MARKET SNAPSHOT, 2018
Figure 28 ASIA PACIFIC: GENE PANELS MARKET SNAPSHOT, 2018
Figure 29 REST OF THE WORLD: GENE PANELS MARKET SNAPSHOT, 2018
Figure 30 KEY DEVELOPMENTS IN THE GENE PANELS MARKET FROM 2015 TO 2018
Figure 31 MARKET EVOLUTION FRAMEWORK
Figure 32 GENE PANEL TEST KITS MARKET SHARE ANALYSIS, BY KEY PLAYER (2017)
Figure 33 ILLUMINA, INC.: COMPANY SNAPSHOT (2017)
Figure 34 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017)
Figure 35 AGILENT: COMPANY SNAPSHOT (2017)
Figure 36 QIAGEN: COMPANY SNAPSHOT (2017)
Figure 37 EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2017)
Figure 38 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2017)
Figure 1 GENE PANELS MARKET SEGMENTATION
Figure 2 RESEARCH DESIGN
Figure 3 KEY DATA FROM SECONDARY SOURCES
Figure 4 KEY DATA FROM PRIMARY SOURCES
Figure 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
Figure 6 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
Figure 7 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 8 DATA TRIANGULATION METHODOLOGY
Figure 9 GENE PANELS MARKET, BY TYPE, 2018 VS. 2023 (USD BILLION)
Figure 10 GENE PANELS MARKET, BY TECHNIQUE, 2018 VS. 2023 (USD BILLION)
Figure 11 GENE PANELS MARKET, BY DESIGN, 2018 VS. 2023 (USD BILLION)
Figure 12 GENE PANELS MARKET, BY APPLICATION, 2018 VS. 2023 (USD BILLION)
Figure 13 GENE PANELS MARKET, BY END USER, 2018 VS. 2023 (USD BILLION)
Figure 14 GLOBAL GENE PANELS MARKET, BY REGION, 2018–2023
Figure 15 INCREASING PREVALENCE OF CHRONIC DISEASES ONE OF THE MAJOR FACTORS DRIVING THE GROWTH OF THE GLOBAL GENE PANELS MARKET
Figure 16 TESTING SERVICES SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 17 RESEARCH AND ACADEMIC INSTITUTES TO CONTINUE TO DOMINATE THE GENE PANELS MARKET IN 2023
Figure 18 CANCER RISK ASSESSMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE GENE PANELS MARKET IN EUROPE IN 2018
Figure 19 US TO DOMINATE THE GENE PANELS MARKET IN 2018
Figure 20 GENE PANELS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
Figure 21 TEST KITS ACCOUNTED FOR LARGEST SHARE OF THE GENE PANELS MARKET IN 2018
Figure 22 AMPLICON-BASED APPROACH TO RESISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
Figure 23 PREDESIGNED GENE PANELS TO ACCOUNT FOR THE LARGEST SHARE OF THE GENE PANELS MARKET IN 2018
Figure 24 CANCER RISK ASSESSMENT ACCOUNTED FOR LARGEST SHARE OF THE GENE PANELS MARKET IN 2018
Figure 25 RESEARCH & ACADEMIC INSTITUTES TO ACCOUNT FOR LARGEST SHARE OF THE GENE PANELS MARKET IN 2018
Figure 26 NORTH AMERICA: GENE PANELS MARKET SNAPSHOT, 2018
Figure 27 EUROPE: GENE PANELS MARKET SNAPSHOT, 2018
Figure 28 ASIA PACIFIC: GENE PANELS MARKET SNAPSHOT, 2018
Figure 29 REST OF THE WORLD: GENE PANELS MARKET SNAPSHOT, 2018
Figure 30 KEY DEVELOPMENTS IN THE GENE PANELS MARKET FROM 2015 TO 2018
Figure 31 MARKET EVOLUTION FRAMEWORK
Figure 32 GENE PANEL TEST KITS MARKET SHARE ANALYSIS, BY KEY PLAYER (2017)
Figure 33 ILLUMINA, INC.: COMPANY SNAPSHOT (2017)
Figure 34 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017)
Figure 35 AGILENT: COMPANY SNAPSHOT (2017)
Figure 36 QIAGEN: COMPANY SNAPSHOT (2017)
Figure 37 EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2017)
Figure 38 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2017)
